<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01529775</url>
  </required_header>
  <id_info>
    <org_study_id>3008</org_study_id>
    <nct_id>NCT01529775</nct_id>
  </id_info>
  <brief_title>Randomized Study of Osseotite Certain Tapered Prevails vs. Osseotite Certain Tapered</brief_title>
  <acronym>Bolivar</acronym>
  <official_title>A Prospective Randomized-controlled Evaluation of the Osseotite Certain Tapered Prevail Implant for the Preservation of Crestal Bone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will demonstrate the benefits of platform switching design of the Osseotite dental
      implant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Osseotite Certain Prevail implant with its platform switch feature will demonstrate
      higher success rate than the non-platform Osseotite Certain implant
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Success Rate</measure>
    <time_frame>3 years</time_frame>
    <description>An implant will be considered successful if it is immobile when tested at various study time point</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Crestal Bone Regression</measure>
    <time_frame>3 years</time_frame>
    <description>Differences in crestal bone levels obtained at various study time points will be compared between the two implant designs</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Partial Edentulism</condition>
  <condition>Tooth Disease</condition>
  <arm_group>
    <arm_group_label>Osseotite Certain Tapered Prevail</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Osseotite Certain Tapered Prevail design with platform switching feature</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Osseotite Certain Tapered</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Osseotite Certain Tapered implant with non-platform switching design</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Osseotite Certain Tapered Prevail</intervention_name>
    <description>Osseotite implant with platform switching feature</description>
    <arm_group_label>Osseotite Certain Tapered Prevail</arm_group_label>
    <other_name>Osseotite endosseous dental implant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Osseotite Certain Tapered</intervention_name>
    <description>Osseotite implant with non-platform switching feature</description>
    <arm_group_label>Osseotite Certain Tapered</arm_group_label>
    <other_name>Osseotite endosseous dental implant</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients of either sex and older than 18 years of age

          -  patients needing at least one dental implant to treat partial edentulism

          -  patients physically able to tolerate surgical and restorative dental procedures

          -  patients agreeing to all protocol visits

        Exclusion Criteria:

          -  patients with infection or severe inflammation at the intended treatment sites

          -  patients smoking greater than 10 cigarettes per day

          -  patients with uncontrolled diabetes mellitus

          -  patients with uncontrolled metabolic diseases

          -  patients who received radiation treatment to the head in the past 12 months

          -  patients needing bone grafting at the intended treatment sites

          -  patients known to be pregnant at screening visit

          -  patients with para-functional habits like bruxing and clenching
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manuel Pavez, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Finis Terrae</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad Finis Terrae</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2012</study_first_submitted>
  <study_first_submitted_qc>February 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2012</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>partial edentulism</keyword>
  <keyword>dental implants</keyword>
  <keyword>Osseotite Certain Prevail Tapered</keyword>
  <keyword>Osseotite Certain Tapered</keyword>
  <keyword>Crestal bone level</keyword>
  <keyword>randomized</keyword>
  <keyword>clinical study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Povidone-Iodine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

